Aytu BioScience AYTU
$ 1.58
6.04%
Quarterly report 2024-Q3
added 11-13-2024
Aytu BioScience Balance Sheet 2011-2024 | AYTU
Annual Balance Sheet Aytu BioScience
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-8.42 M | -7.01 M | -3.85 M | -48.5 M | -45.6 M | -11 M | -7.01 M | -802 K | -8.05 M | -7.35 M | -2.64 M | 97.6 K | 67.9 K | 48.3 K |
Long Term Debt |
10.9 M | 14.7 M | 14.3 M | 180 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
712 K | 1.26 M | 1.23 M | 940 K | 300 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
28.2 M | 28.1 M | - | - | 29.5 M | 22.3 M | 4.24 M | 7.39 M | 4.15 M | 1.13 M | 554 K | - | - | - |
Total Current Liabilities |
62.2 M | 69 M | 64.4 M | 109 M | 28.3 M | 5.37 M | 3.39 M | 3.61 M | 10.1 M | 1.48 M | - | 121 K | 82.4 K | - |
Total Liabilities |
- | - | 93.3 M | 128 M | 57.8 M | 27.6 M | 7.64 M | 11 M | 14.3 M | 2.61 M | 6.65 M | 121 K | 82.4 K | 58.4 K |
Deferred Revenue |
- | - | - | - | 339 K | - | - | - | - | 85.7 K | 85.7 K | - | - | - |
Retained Earnings |
-320 M | -304 M | -287 M | -178 M | -120 M | -106 M | -79.3 M | -69.1 M | -46.6 M | -18.4 M | -10.7 M | -569 K | -500 | -500 |
Total Assets |
118 M | 136 M | 138 M | 266 M | 153 M | 34.7 M | 21.1 M | 15 M | 24.3 M | 18.2 M | 12 M | 9.67 K | 12.6 K | 22.8 K |
Cash and Cash Equivalents |
20 M | 23 M | 19.4 M | 49.6 M | 48.1 M | 11 M | 7.01 M | 802 K | 8.05 M | 7.35 M | 2.64 M | 1.86 K | 109 | 3.99 K |
Book Value |
118 M | 136 M | 44.3 M | 138 M | 95 M | 7.09 M | 13.4 M | 4 M | 10.1 M | 15.6 M | 5.37 M | -111 K | -69.7 K | -35.6 K |
Total Shareholders Equity |
27.7 M | 39.4 M | 44.3 M | 138 M | 95 M | 7.09 M | 13.4 M | 4 M | 10.1 M | 15.6 M | 5.37 M | -111 K | -69.7 K | -35.6 K |
All numbers in USD currency
Quarterly Balance Sheet Aytu BioScience
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
10.4 M | 10.9 M | - | 15 M | 15 M | 14.7 M | 15 M | 15 M | 15 M | 15 M | 15 M | 129 K | 154 K | 180 K | 180 K | 211 K | 237 K | - | 8.16 M | 23.4 M | 314 K | - | 5.13 M | 5.04 M | - | 5.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
24.8 M | 28.2 M | 14.4 M | 34.2 M | - | 28.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 101 M | 97.1 M | 106 M | 95.6 M | 96.1 M | 93.3 M | 108 M | 118 M | 116 M | 128 M | 128 M | 54 M | 50.2 M | 58.3 M | 57.8 M | 57.4 M | 28.7 M | 27.6 M | 27.6 M | 22.5 M | 7.85 M | 22.5 M | 7.64 M | 15.8 M | 14.9 M | 11 M | 11 M | 11.1 M | 13 M | 14.3 M | 14.3 M | 9.15 M | 7.95 M | 2.57 M | 2.61 M | - | 6.66 M | 6.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | 100 K | 100 K | 400 K | 100 K | 200 K | 200 K | 200 K | 200 K | 476 K | 233 K | 339 K | 339 K | - | - | - | - | 14 K | - | 14 K | - | - | - | - | - | - | - | - | 85.7 K | 85.7 K | 85.7 K | 85.7 K | 85.7 K | - | 85.7 K | 85.7 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-318 M | -320 M | -315 M | -312 M | -312 M | -304 M | -302 M | -294 M | -291 M | -287 M | -271 M | -218 M | -206 M | -178 M | -178 M | -134 M | -124 M | -120 M | -120 M | -112 M | -111 M | -106 M | -106 M | -87.4 M | -82.7 M | -87.4 M | -79.3 M | -77 M | -73.3 M | -69.1 M | -69.1 M | -57.1 M | -52.3 M | -46.6 M | -46.6 M | -24 M | -20.7 M | -18.4 M | -18.4 M | -646 K | -630 K | -10.7 M | -630 K | -500 | -500 | -500 | -500 | -500 | -500 | -500 | -500 | -500 | -500 | -500 | -500 |
Total Assets |
116 M | 118 M | 129 M | 131 M | 133 M | 136 M | 147 M | 141 M | 150 M | 138 M | 169 M | 224 M | 228 M | 266 M | 266 M | 167 M | 141 M | 153 M | 153 M | 74.5 M | 31 M | 34.7 M | 34.7 M | 42.4 M | 18 M | 42.4 M | 21.1 M | 18.9 M | 21.2 M | 15 M | 15 M | 21.5 M | 15 M | 21.5 M | 20.2 M | 24.4 M | 21.4 M | 18.2 M | 18.2 M | 11.2 K | 5.51 K | 12 M | 5.51 K | 7.16 K | 9.67 K | 9.67 K | 9.67 K | 11.9 K | 12.6 K | 12.6 K | 12.6 K | 18.8 K | 22.8 K | 22.8 K | 22.8 K |
Cash and Cash Equivalents |
20.1 M | 20 M | 19.8 M | 19.5 M | 20 M | 23 M | 19.2 M | 19.5 M | 23.8 M | 19.4 M | 27.6 M | 35.3 M | 40.3 M | 49.9 M | 49.6 M | 62 M | 37.9 M | 62 M | 37.9 M | 5.26 M | 7.01 M | 11 M | 11 M | 17.8 M | 3.96 M | 17.8 M | 7.01 M | 3.91 M | 7.02 M | 802 K | 802 K | 5.23 M | 2.75 M | 8.05 M | 8.05 M | 11 M | 10.1 M | 11 M | 10.1 M | 161 K | 1.05 M | 2.64 M | 4.12 M | 445 | 1.86 K | 2.91 M | 445 | 701 | 109 | 109 | 701 | 1.72 K | 3.99 K | 3.99 K | 1.72 K |
Book Value |
- | - | - | - | 32.2 M | 39.4 M | 40.9 M | 45.8 M | 53.9 M | 44.3 M | 61.1 M | 106 M | 112 M | 138 M | 138 M | 113 M | 91.1 M | 95 M | 95 M | 17.1 M | 2.32 M | 7.09 M | 7.09 M | 19.9 M | 10.1 M | 19.9 M | 13.4 M | 3.03 M | 6.35 M | 4 M | 4 M | 10.4 M | 1.99 M | 7.25 M | 5.94 M | 15.3 M | 13.4 M | 15.6 M | 15.6 M | 11.2 K | -6.65 M | 5.37 M | 5.51 K | 7.16 K | 9.67 K | 9.67 K | 9.67 K | 11.9 K | 12.6 K | 12.6 K | 12.6 K | 18.8 K | 22.8 K | 22.8 K | 22.8 K |
Total Shareholders Equity |
29.8 M | 27.7 M | 30.8 M | 32.9 M | 32.2 M | 39.4 M | 40.9 M | 45.8 M | 48.3 M | 44.3 M | 57.7 M | 106 M | 112 M | 138 M | 138 M | 113 M | 113 M | 113 M | 91.1 M | 17.1 M | 17.1 M | 17.1 M | 2.32 M | 19.9 M | 19.9 M | 19.9 M | 10.1 M | 3.03 M | 6.35 M | 3.03 M | 6.35 M | 10.4 M | 7.19 M | 10.1 M | 10.1 M | 15.3 M | 13.4 M | 15.6 M | 15.6 M | -44.1 K | -45 K | 5.37 M | -45 K | -126 K | -111 K | -111 K | -111 K | -82.2 K | -69.7 K | -69.7 K | -69.7 K | -47.6 K | -35.6 K | -35.6 K | -35.6 K |
All numbers in USD currency